The ASX was trading amid volatility this morning, swinging between modest gains and losses as Wall Street’s nerves set off a ...

Subsequently, subdermal needle electrodes were strategically placed at the vertex of the skull to serve as the active electrode, while a reference electrode was positioned beneath the left ear, and a ...

Goldman Sachs analyst expects positive updates from Vertex's first Investor Day as a public company on March 19, reiterates ...

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

Forensics crews with evidence markers at a shooting investigation (Dorez Wynn/CBS 17) Forensics crews with evidence markers at a shooting investigation (Dorez Wynn/CBS 17) Forensics crews at a ...

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close. Amicus Therapeutics (FOLD) reported earnings 30 days ago.

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...